kabutan

artience rebounds on subsidiary's partnership agreement with Daito Pharma

Fri Apr 10, 2026 9:44 am JST Catalyst

Shares of Artience <4634> rebounded. After the market close on the 9th, the company announced that its subsidiary, Toyo Chem, had entered into an agreement to build a partnership with Daito Pharmaceutical <4577>, a move that was welcomed by the market. The two companies will leverage their respective strengths?Toyo Chem's formulation development capabilities and production systems for transdermal formulations, and Daito Pharma's expertise in domestic and international clinical trials, regulatory affairs, and quality assurance, alongside its high-quality, stable manufacturing systems for active pharmaceutical ingredients?to actively initiate discussions on a joint business to develop, manufacture, and commercialize high-value-added formulations.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles